Information  X 
Enter a valid email address

A2Dominion Housing (54XE)

  Print      Mail a friend

Friday 14 September, 2018

A2Dominion Housing

Publication of Updated EMTN Base Prospectus

RNS Number : 8579A
A2Dominion Housing Group Ltd
14 September 2018
 

Publication of Updated EMTN Programme Base Prospectus

 

 

A2Dominion Housing Group Limited

14 September 2018

 

The following base prospectus (the Base Prospectus) has been approved by the UK Listing Authority and is available for viewing:

Base Prospectus dated 14 September 2018 relating to the £1,000,000,000 Euro Medium Term Note Programme of A2Dominion Housing Group Limited

To view the full document, please paste the following URL into the address bar of your browser.

https://www.a2dominiongroup.co.uk/about/investors

A copy of the Base Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM

For further information, please contact:

 

Ellie Lodge

The Point

37 North Wharf Road

London

W2 1BD

Telephone: 020 8825 1640

Fax: 020 8825 1963

Email: [email protected]

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed.  Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PDIUSOURWSAKAAR

a d v e r t i s e m e n t